Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

152 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The CYP2C19*17 allele is associated with better platelet response to clopidogrel in patients admitted for non-ST acute coronary syndrome.
Frére C, Cuisset T, Gaborit B, Alessi MC, Hulot JS. Frére C, et al. J Thromb Haemost. 2009 Aug;7(8):1409-11. doi: 10.1111/j.1538-7836.2009.03500.x. Epub 2009 May 30. J Thromb Haemost. 2009. PMID: 19496924 No abstract available.
High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome.
Cuisset T, Frere C, Quilici J, Barbou F, Morange PE, Hovasse T, Bonnet JL, Alessi MC. Cuisset T, et al. J Thromb Haemost. 2006 Mar;4(3):542-9. doi: 10.1111/j.1538-7836.2005.01751.x. Epub 2005 Dec 22. J Thromb Haemost. 2006. PMID: 16371119 Clinical Trial.
TAFI levels in patients with acute myocardial infarction treated with thrombolysis.
Frere C, Renard S, Gils A, Van De Werf F, Alessi MC. Frere C, et al. J Thromb Haemost. 2005 Feb;3(2):395-7. doi: 10.1111/j.1538-7836.2005.01107.x. J Thromb Haemost. 2005. PMID: 15670056 No abstract available.
CD11b+ leukocyte microparticles are associated with high-risk angiographic lesions and recurrent cardiovascular events in acute coronary syndromes.
Faille D, Frere C, Cuisset T, Quilici J, Moro PJ, Morange PE, Bonnet JL, Alessi MC. Faille D, et al. J Thromb Haemost. 2011 Sep;9(9):1870-3. doi: 10.1111/j.1538-7836.2011.04418.x. J Thromb Haemost. 2011. PMID: 21707910 No abstract available.
Enhanced post-clopidogrel platelet reactivity in diabetic patients is independently related to plasma fibrinogen level but not to glycemic control.
Gaborit B, Frère C, Cuisset T, Alessi MC, Dutour A. Gaborit B, et al. J Thromb Haemost. 2009 Nov;7(11):1939-41. doi: 10.1111/j.1538-7836.2009.03599.x. J Thromb Haemost. 2009. PMID: 20015321 No abstract available.
[Beneficial effect of a loading dose of 600 mg of clopidogrel on platelet parameters in patients admitted for acute coronary syndrome].
Cuisset T, Frère C, Quilici J, Morange PE, Saidi LN, Carvajal J, Lambert M, Mouret JP, Alessi MC, Bonnet JL. Cuisset T, et al. Arch Mal Coeur Vaiss. 2006 Oct;99(10):889-93. Arch Mal Coeur Vaiss. 2006. PMID: 17100139 French.
Meta-Analysis of Potent P2Y12-ADP Receptor Antagonist Therapy Compared to Clopidogrel Therapy in Acute Coronary Syndrome Patients with Chronic Kidney Disease.
Bonello L, Laine M, Lemesle G, Puymirat E, Dabry T, Thuny F, Paganelli F, Aradi D, Frere C, Burtey S, Sibbing D, Mancini J. Bonello L, et al. Thromb Haemost. 2018 Oct;118(10):1839-1846. doi: 10.1055/s-0038-1669426. Epub 2018 Sep 20. Thromb Haemost. 2018. PMID: 30235475
Onset of optimal P2Y12-ADP receptor blockade after ticagrelor and prasugrel intake in Non-ST elevation acute coronary syndrome.
Bonello L, Laine M, Camoin-Jau L, Noirot F, Guieu R, Dignat-George F, Paganelli F, Frere C. Bonello L, et al. Thromb Haemost. 2015 Oct;114(4):702-7. doi: 10.1160/TH15-02-0149. Epub 2015 Aug 27. Thromb Haemost. 2015. PMID: 26311415 Clinical Trial.
Ticagrelor versus prasugrel in diabetic patients with an acute coronary syndrome. A pharmacodynamic randomised study.
Laine M, Frère C, Toesca R, Berbis J, Barnay P, Pansieri M, Michelet P, Bessereau J, Camilleri E, Ronsin O, Helal O, Paganelli F, Dignat-George F, Bonello L. Laine M, et al. Thromb Haemost. 2014 Feb;111(2):273-8. doi: 10.1160/TH13-05-0384. Epub 2013 Oct 24. Thromb Haemost. 2014. PMID: 24154787 Clinical Trial.
152 results
Jump to page